Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Alster

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Neurologia I Neurochirurgia Polska|December 15, 2022
Could hyperlipidemia be a risk factor for corticobasal syndrome? - a pilot studyNatalia Madetko-Alster, Piotr Alster, Tereza Bartošová, et al.
Journal of Clinical Medicine|January 23, 2024
Glucose Metabolism and Cognitive Decline in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Preliminary StudyNatalia Madetko-Alster, Dagmara Otto-Ślusarczyk, Marta Struga, et al.
International Journal of Molecular Sciences|December 30, 2025
Inflammatory and Neurotrophic Factors and Their Connection to Quality of Life in Progressive Supranuclear Palsy-Single-Center StudyMichał Markiewicz, Bartosz Migda, Dagmara Otto-Ślusarczyk, et al.
Diseases (Basel, Switzerland)|April 25, 2025
Possible Significance of Neutrophil-Hemoglobin Ratio in Differentiating Progressive Supranuclear Palsy from Depression: A Pilot StudyMichał Markiewicz, Natalia Madetko-Alster, Dagmara Otto-Ślusarczyk, et al.
Frontiers in Immunology|August 23, 2024
The associations between common neuroimaging parameters of Progressive Supranuclear Palsy in magnetic resonance imaging and non-specific inflammatory factors - pilot studyPiotr Alster, Dagmara Otto-Ślusarczyk, Michał Kutyłowski, et al.
Neurologia I Neurochirurgia Polska|July 21, 2018
Difficulties in the diagnosis of four repeats (4R) tauopathic parkinsonian syndromesPiotr Alster, Ewa Krzyżanowska, Dariusz Koziorowski, et al.
Biomedicines|October 17, 2020
The Links between Parkinson's Disease and CancerMaria Ejma, Natalia Madetko, Anna Brzecka, et al.
Frontiers in Neurology|February 22, 2021
The Role of Frontal Assessment Battery and Frontal Lobe Single-Photon Emission Computed Tomography in the Differential Diagnosis of Progressive Supranuclear Palsy Variants and Corticobasal Syndrome-A Pilot StudyPiotr Alster, Bartosz Migda, Natalia Madetko, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
The Strengths and Obstacles in the Differential Diagnosis of Progressive Supranuclear Palsy-Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA) Using Magnetic Resonance Imaging (MRI) and Perfusion Single Photon Emission Computed Tomography (SPECT)Piotr Alster, Michał Nieciecki, Bartosz Migda, et al.
International Journal of Molecular Sciences|December 17, 2024
Possible Impact of Peripheral Inflammatory Factors and Interleukin-1β (IL-1β) on Cognitive Functioning in Progressive Supranuclear Palsy-Richardson Syndrome (PSP-RS) and Progressive Supranuclear Palsy-Predominant Parkinsonism (PSP-P)Patryk Chunowski, Dagmara Otto-Ślusarczyk, Karolina Duszyńska-Wąs, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Neurologia I Neurochirurgia Polska|December 15, 2022
Could hyperlipidemia be a risk factor for corticobasal syndrome? - a pilot studyNatalia Madetko-Alster, Piotr Alster, Tereza Bartošová, et al.
Journal of Clinical Medicine|January 23, 2024
Glucose Metabolism and Cognitive Decline in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Preliminary StudyNatalia Madetko-Alster, Dagmara Otto-Ślusarczyk, Marta Struga, et al.
International Journal of Molecular Sciences|December 30, 2025
Inflammatory and Neurotrophic Factors and Their Connection to Quality of Life in Progressive Supranuclear Palsy-Single-Center StudyMichał Markiewicz, Bartosz Migda, Dagmara Otto-Ślusarczyk, et al.
Diseases (Basel, Switzerland)|April 25, 2025
Possible Significance of Neutrophil-Hemoglobin Ratio in Differentiating Progressive Supranuclear Palsy from Depression: A Pilot StudyMichał Markiewicz, Natalia Madetko-Alster, Dagmara Otto-Ślusarczyk, et al.
Frontiers in Immunology|August 23, 2024
The associations between common neuroimaging parameters of Progressive Supranuclear Palsy in magnetic resonance imaging and non-specific inflammatory factors - pilot studyPiotr Alster, Dagmara Otto-Ślusarczyk, Michał Kutyłowski, et al.
Neurologia I Neurochirurgia Polska|July 21, 2018
Difficulties in the diagnosis of four repeats (4R) tauopathic parkinsonian syndromesPiotr Alster, Ewa Krzyżanowska, Dariusz Koziorowski, et al.
Biomedicines|October 17, 2020
The Links between Parkinson's Disease and CancerMaria Ejma, Natalia Madetko, Anna Brzecka, et al.
Frontiers in Neurology|February 22, 2021
The Role of Frontal Assessment Battery and Frontal Lobe Single-Photon Emission Computed Tomography in the Differential Diagnosis of Progressive Supranuclear Palsy Variants and Corticobasal Syndrome-A Pilot StudyPiotr Alster, Bartosz Migda, Natalia Madetko, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
The Strengths and Obstacles in the Differential Diagnosis of Progressive Supranuclear Palsy-Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA) Using Magnetic Resonance Imaging (MRI) and Perfusion Single Photon Emission Computed Tomography (SPECT)Piotr Alster, Michał Nieciecki, Bartosz Migda, et al.
International Journal of Molecular Sciences|December 17, 2024
Possible Impact of Peripheral Inflammatory Factors and Interleukin-1β (IL-1β) on Cognitive Functioning in Progressive Supranuclear Palsy-Richardson Syndrome (PSP-RS) and Progressive Supranuclear Palsy-Predominant Parkinsonism (PSP-P)Patryk Chunowski, Dagmara Otto-Ślusarczyk, Karolina Duszyńska-Wąs, et al.
Pageof 6